Filing Details

Accession Number:
0001179110-13-017561
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-06 17:05:45
Reporting Period:
2013-12-04
Filing Date:
2013-12-06
Accepted Time:
2013-12-06 17:05:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1113481 Medicines Co MDCO Pharmaceutical Preparations (2834) 043324394
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1277478 Glenn Sblendorio 8 Sylvan Way
Parsippany NJ 07054
President & Cfo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-04 8,190 $20.11 126,595 No 4 M Direct
Common Stock Disposition 2013-12-04 8,190 $38.50 118,405 No 4 S Direct
Common Stock Acquisiton 2013-12-05 326 $20.11 118,731 No 4 M Direct
Common Stock Disposition 2013-12-05 326 $38.50 118,405 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right-to-buy) Disposition 2013-12-04 8,190 $0.00 8,190 $20.11
Common Stock Stock Option (right-to-buy) Disposition 2013-12-05 326 $0.00 326 $20.11
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
326 2016-03-03 No 4 M Direct
0 2016-03-03 No 4 M Direct
Footnotes
  1. This sale was effected pursuant to a Rule 10b5-1 plan adopted by Mr. Sblendorio on April 11, 2013.
  2. These stock options were part of a grant made on March 3, 2006 where 25% of the option vested on March 3, 2007 and the remainder of the option vested in 36 equal monthly installments beginning April 3, 2007.